7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple...
Tumor markers allowed for evaluable disease. *Positive bone scan, osteoblastic metastases, and pleural or peritoneal effusions ... No prior allergic reactions attributed to compounds of similar chemical or biological composition to UCN-01 or irinotecan ... Gastrointestinal Stromal Tumor HER2-negative Breast Cancer Metastatic Gastrointestinal Carcinoid Tumor Ovarian Sarcoma Ovarian ... Determine the anti-tumor activity in terms of overall response rate (partial response [PR] and complete response [CR]), ...https://clinicaltrials.gov/ct2/show/NCT00031681?term=Breast+Cancer&lup_s=12%2F17%2F2012&lup_d=30
Tumor marker - Wikipedia
Tumor Markers, Biological at the US National Library of Medicine Medical Subject Headings (MeSH). ... Tumor markers can be produced directly by the tumor or by non-tumor cells as a response to the presence of a tumor. Although ... Staging: some tumor markers are included in the staging procedures for some tumor localizations. Prognosis to plan the ... Kaura, B; Bagga, R; Patel, FD (2004). "Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for ...https://en.wikipedia.org/wiki/Tumor_marker
Comparative cytokeratin expressio... preview & related info | Mendeley
Mucoepidermoid carcinoma is the most common malignant salivary gland tumor, composed of several different cell types, with ... Tumor Markers, Biological. *Young Adult. *classification. *metabolism. *pathology. Get free article suggestions today. Mendeley ... Mucoepidermoid carcinoma is the most common malignant salivary gland tumor, composed of several different cell types, with ... in order to establish a possible correlation between tumor cells immunostaining and mucoepidermoid carcinoma histogenesis and ...https://www.mendeley.com/research-papers/comparative-cytokeratin-expression-different-cell-types-salivary-gland-mucoepidermoid-carcinoma/
FLAXSEED: Uses, Side Effects, Interactions and Warnings - WebMD
Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005;11:3828-35. View ... Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast ... Early research shows that eating a muffin containing 25 grams of flaxseed daily for about 40 days reduces tumor cell growth in ... Early research suggests that taking flaxseed and following a low-fat diet can lower prostate-specific antigen (PSA), a marker ...https://www.webmd.com/vitamins-supplements/ingredientmono-991-FLAXSEED.aspx?activeIngredientId=991&activeIngredientName=FLAXSEED&source=2
Center for Theoretical & Mathematical Sciences » People
Tumor Markers, Biological • Tyrosine • Tyrosine 3-Monooxygenase • United States • Up-Regulation • Vacuoles • Vitamin B 12 ... Biological Evolution • Biological Markers • Biological Transport • Biomass • Biometry • Body Constitution • Body Patterning • ... Nijhout, HF; Reed, MC; Ulrich, CM, A day in the life of cell metabolism., Biological Theory (in press) (2007) *H.F. Nijhout, ... Nijhout, HF; Suzuki, Y, Environment and genetic accommodation., Biological Theory, vol. 3 no. 1-9 (2009) *Suzuki Y, Nijhout HF ...http://fds.duke.edu/db/aas/math/ctms/faculty/hfn
Frontiers | The Effect of Flaxseed in Breast Cancer: A Literature Review | Nutrition
Other animal studies found that the intake of flaxseed combined with tamoxifen can reduce tumor size to a greater extent than ... Other animal studies found that the intake of flaxseed combined with tamoxifen can reduce tumor size to a greater extent than ... Dietary flaxseeds alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res (2005) 11(10):3828-35. doi: ... Breast tumors that contain estrogen receptors are called estrogen receptor positive (ER+) and tumors that lack estrogen ...https://www.frontiersin.org/articles/10.3389/fnut.2018.00004/full
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer.
... we evaluated the prognostic value of the tumour marker, tissue polypeptide-specific antigen (TPS), in 203 patients with non- ... 0/Peptides; 0/Tissue Polypeptide Antigen; 0/Tumor Markers, Biological; EC 126.96.36.199/L-Lactate Dehydrogenase; EC 188.8.131.52/gamma- ... In this study, we evaluated the prognostic value of the tumour marker, tissue polypeptide-specific antigen (TPS), in 203 ... Previous Document: Adult Wilms' tumour: review of 22 cases.. Next Document: In vivo cell kinetic measurements in human ...http://www.biomedsearch.com/nih/Prognostic-significance-tissue-polypeptide-specific/7880606.html
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.
... is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The ... 0/Antigens; 0/Proteoglycans; 0/Tumor Markers, Biological; 0/chondroitin sulfate proteoglycan 4 ... B brain, S guide-screw, T tumour, n number of animals (adapted from ). b Tumour sizes in vivo before IR treatment (top ... 6a). The 125I seeds delivered a dose of 1.8 Gy Bio Equivalent Dosetumour (BEDtumour) for 12 days at 2.5 mm below the seed, 2.7 ...http://www.biomedsearch.com/nih/Expression-progenitor-marker-predicts-poor/21863242.html
Personalized oncology in interventional radiology.
0/Antineoplastic Agents; 0/Tumor Markers, Biological Comments/Corrections. From MEDLINE®/PubMed®, a database of the U.S. ... Several mutations and key markers already have been introduced into standard oncologic practice. A broader understanding of ... and tumor angiogenesis. A new era of personalized medicine has evolved whereby clinical decisions are adjusted according to a ...http://www.biomedsearch.com/nih/Personalized-oncology-in-interventional-radiology/23885909.html
Intramedullary endometriosis of the conus medullaris: case report.
Tumor Markers, Biological / analysis, metabolism. Urinary Bladder, Neurogenic / diagnosis, etiology, physiopathology. Chemical ...http://www.biomedsearch.com/nih/Intramedullary-endometriosis-conus-medullaris-case/16883155.html
Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
0/KRAS protein, human; 0/Proto-Oncogene Proteins; 0/Tumor Markers, Biological; EC 184.108.40.206/EGFR protein, human; EC 220.127.116.11/ ...http://www.biomedsearch.com/nih/Combined-Use-ALK-Immunohistochemistry-FISH/23407557.html
Medical devices; reclassification of tumor-associated antigen immunological test system--FDA. Final rule.
... is announcing that it is codifying the reclassification of tumor-associated antigen immunological test systems intended as an ... Tumor Markers, Biological / classification*, standards. United States. United States Food and Drug Administration. ... reclassifying serum tumor markers into class II. This action is being taken under the Federal Food, Drug, and Cosmetic Act (the ... The Food and Drug Administration (FDA) is announcing that it is codifying the reclassification of tumor-associated antigen ...http://www.biomedsearch.com/nih/Medical-reclassification-tumor-associated-antigen/10179301.html
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.
Tumor Markers, Biological / genetics. Tumor Suppressor Protein p53 / genetics, metabolism. Urinary Bladder Neoplasms / ... 0/Tumor Markers, Biological; 0/Tumor Suppressor Protein p53; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 18.104.22.168/PIK3CA ... Additionally, in primary tumors p53 expression was obtained by immunohistochemistry. Of primary tumors 64% were mutant for ... In patients presenting with NMI-BC grade 3 and MI-BC, 33 and 36% of the primary tumors were mutant. In patients with low-grade ...http://www.biomedsearch.com/nih/Fgfr3-hras-kras-nras-pik3ca/21072204.html
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Tumor Markers, Biological / metabolism. Urinary Bladder Neoplasms / metabolism, pathology*, surgery. Chemical. Reg. No./ ... The tumor cells are negative for E-cadherin, but positive for CD138 expression. This particular patient died 3 months after the ... CONCLUSIONS: PUC is a rare tumor associated with poor prognosis due to its advanced clinical stage upon its diagnosis. The ... The patient underwent radical cystectomy, and the representative sections of tumor were submitted for immunohistochemical ...http://www.biomedsearch.com/nih/Plasmacytoid-urothelial-carcinoma-urinary-bladder/22949945.html
Benign mesenchymal tumours and tumour-like lesions in end-stage renal disease.
0/Tumor Markers, Biological ... Benign mesenchymal tumours and tumour-like lesions in end-stage ... Tumour-like smooth muscle proliferations were seen surrounding muscular arteries (eight), occasionally admixed with fat ...http://www.biomedsearch.com/nih/Benign-mesenchymal-tumours-tumour-like/23020314.html
Circulating neuroendocrine markers in patients with prostate carcinoma.
Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic intraepithelial neoplasia ... 0/Chromogranin A; 0/Chromogranins; 0/Tumor Markers, Biological; EC 22.214.171.124/Phosphopyruvate Hydratase ... Next Document: MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance.... ... BACKGROUND: Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic ...http://www.biomedsearch.com/nih/Circulating-neuroendocrine-markers-in-patients/10861438.html
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
0/Antigens, CD; 0/Antineoplastic Agents, Alkylating; 0/Isoenzymes; 0/Tumor Markers, Biological; 305-03-3/Chlorambucil; EC 3.1.3 ... Previous Document: D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tum.... ...http://www.biomedsearch.com/nih/Hairy-cell-leukemia-variant-in/21326814.html
Preventing Breast Cancer with Flax Seeds | NutritionFacts.org
Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005 May 15;11(10):3828-35. ... Plant had been measuring a persistent cancer tumor in her neck with calipers. She stopped eating dairy, the tumor linearly ... In the Kansas study, about 20% of the women saw an increase in Ki-67 markers, and 3 of those were sharp increases! Can you ... How do you know if you'd end up in the 80% with decreased markers or the 20% with increased ones?) The cumulative evidence from ...https://nutritionfacts.org/2016/05/26/preventing-breast-cancer-with-flax-seeds/?utm_source=rss&utm_medium=rss&utm_campaign=preventing-breast-cancer-with-flax-seeds&utm_source=NutritionFacts.org&utm_campaign=4e01d3a6d9-RSS_BLOG_DAILY&utm_medium=email&utm_term=0_40f9e497d1-4e01d3a6d9-23574253
Ultra-fast processing of gigapixel Tissue MicroArray images using high performance computing. - NextBio article
Tumor Markers, Biological Substances Tumor Markers, Biological PMID: 21127378. View Full Text ...http://www.nextbio.com/b/search/article.nb?id=21127378
Reduction in Ki-67 in Benign Breast Tissue of High Risk Women with the Lignan Secoisolariciresinol Diglycoside (SDG)
Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005;11:3828-35. [PubMed] ... Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23:7212-20. [PubMed ... Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat. 2006;99:309-11. [ ... Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007;98:1447-53. [ ...http://pubmedcentralcanada.ca/pmcc/articles/PMC2955777/?lang=en-ca
Retinal Dehydrogenase Summary Report | CureHunter
Biological Tumor Markers (Tumor Markers) 10. Thioredoxins CureHunter Inc. provides medical information and specifically does ... "The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or ...http://www.curehunter.com/public/keywordSummaryD050697-Retinal-Dehydrogenase.do
Chorionic Gonadotropin - Human Chorionic Gonadotropin Summary Report | CureHunter
... but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). ... Biological Markers (Surrogate Marker) 4. Gonadotropins 5. Biological Tumor Markers (Tumor Markers) ... Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 03/13/1992 - "It has an important role in germ cell tumors and in ... 07/01/2005 - "In this study, MA-10 mouse Leydig tumor cells were treated with vehicle, different dosages of TM with or without ...http://www.curehunter.com/public/keywordSummaryD006063-Chorionic-Gonadotropin-Human-Chorionic-Gonadotropin.do
Diverse phenotypic profile of uterine tumors resembling ovarian sex cord tumors: an immunohistochemical study of 12 cases. - de...
Sex Cord-Gonadal Stromal Tumors/pathology/surgery ; Tumor Markers, Biological/metabolism ; Uterine Neoplasms/metabolism/ ... CD10 was positive in 6 of 12 tumors, CD117 in 4 of 12, and S100 in 2 of 11 tumors, whereas HMB45 was negative in 11 tumors ... and smooth muscle markers. The expression of smooth muscle markers in these tumors does not imply a smooth muscle origin as ... with 4 tumors coexpressing more than one marker. Half of the UTROSCTs showed positivity for KL1, with 2 tumors coexpressing ...http://orbi.ulg.ac.be/handle/2268/109972
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. - CAPRARO Valérie
Tumor Markers, Biological/metabolism. Abstract :. [en] OBJECTIVE: Telomeres are protected by tightly regulated factors and ...http://orbi.ulg.ac.be/handle/2268/110202
Pancreatic Cyst Summary Report | CureHunter
Biological Tumor Markers (Tumor Markers)IBA 10/01/2009 - "The purpose of this study was to: (1) identify the diagnostic value ... Biological Markers (Surrogate Marker)IBA 09/01/2014 - "Incremental improvements in pancreatic cyst diagnosis have occurred with ... "Pancreatic cyst fluid tumor markers supplement other diagnostic measures. ". 06/01/2015 - "Analysis of cyst size and tumor ... having low serum tumor markers levels and negativity of CA 72-4 and MCA in the cyst fluid, the diagnosis of the macrocystic ...http://www.curehunter.com/public/keywordSummaryD010181-Pancreatic-Cyst.do
Download our free solidary book to support research on VHL disease